MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum

MLA

Matthew Auton, et al. “MeV-Stealth: A CD46-Specific Oncolytic Measles Virus Resistant to Neutralization by Measles-Immune Human Serum.” PLOS Pathogens, vol. 17, Feb. 2021, p. e1009283. EBSCOhost, https://doi.org/10.1371/journal.ppat.1009283.

APA

Matthew Auton, Lianwen Zhang, Alexander Tischer, Stephen J. Russell, Miguel Ángel Muñoz-Alía, Eugene S. Bah, & Rebecca A. Nace. (2021). MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum. PLOS Pathogens, 17, e1009283. https://doi.org/10.1371/journal.ppat.1009283

Chicago

Matthew Auton, Lianwen Zhang, Alexander Tischer, Stephen J. Russell, Miguel Ángel Muñoz-Alía, Eugene S. Bah, and Rebecca A. Nace. 2021. “MeV-Stealth: A CD46-Specific Oncolytic Measles Virus Resistant to Neutralization by Measles-Immune Human Serum.” PLOS Pathogens 17 (February): e1009283. doi:10.1371/journal.ppat.1009283.